Business Description
Gaush Meditech Ltd
ISIN : KYG3902N1051
Total Employee Number:
893Compare
Compare
Traded in other countries / regions
02407.Hong KongF7Y.Germany Index Membership
Hong Kong Stock Connect IPO Date
2022-12-12Description
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.86 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 2.27 | |||||
Interest Coverage | 7.41 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.19 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | -26.8 | |||||
3-Year Book Growth Rate | 4.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.18 | |||||
9-Day RSI | 42.84 | |||||
14-Day RSI | 45.26 | |||||
3-1 Month Momentum % | -2.89 | |||||
6-1 Month Momentum % | -31.98 | |||||
12-1 Month Momentum % | -33.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.4 | |||||
Quick Ratio | 1.63 | |||||
Cash Ratio | 0.97 | |||||
Days Inventory | 167.93 | |||||
Days Sales Outstanding | 43.78 | |||||
Days Payable | 35.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.12 | |||||
Dividend Payout Ratio | 0.41 | |||||
5-Year Yield-on-Cost % | 6.12 | |||||
Shareholder Yield % | 29.06 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 45.86 | |||||
Operating Margin % | 10.51 | |||||
Net Margin % | 6.97 | |||||
EBITDA Margin % | 16.3 | |||||
FCF Margin % | 8.03 | |||||
OCF Margin % | 10.48 | |||||
ROE % | 5.92 | |||||
ROA % | 3.76 | |||||
ROIC % | 6.07 | |||||
3-Year ROIIC % | -59.76 | |||||
ROC (Joel Greenblatt) % | 40.06 | |||||
ROCE % | 6.38 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.75 | |||||
Forward PE Ratio | 3.22 | |||||
PE Ratio without NRI | 6.75 | |||||
Price-to-Owner-Earnings | 4.68 | |||||
PS Ratio | 0.47 | |||||
PB Ratio | 0.39 | |||||
Price-to-Tangible-Book | 1.61 | |||||
Price-to-Free-Cash-Flow | 5.81 | |||||
Price-to-Operating-Cash-Flow | 4.45 | |||||
EV-to-EBIT | 5.53 | |||||
EV-to-EBITDA | 3.29 | |||||
EV-to-Revenue | 0.54 | |||||
EV-to-FCF | 6.68 | |||||
Price-to-GF-Value | 0.37 | |||||
Price-to-Graham-Number | 0.7 | |||||
| Price-to-Net-Current-Asset-Value | 4.5 | |||||
Earnings Yield (Greenblatt) % | 18.08 | |||||
FCF Yield % | 16.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gaush Meditech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,517.26 | ||
| EPS (TTM) (HK$) | 0.726 | ||
| Beta | -0.0499 | ||
| 3-Year Sharpe Ratio | -1.8 | ||
| 3-Year Sortino Ratio | -1.72 | ||
| Volatility % | 33.13 | ||
| 14-Day RSI | 45.26 | ||
| 14-Day ATR (HK$) | 0.24002 | ||
| 20-Day SMA (HK$) | 4.9905 | ||
| 12-1 Month Momentum % | -33.07 | ||
| 52-Week Range (HK$) | 4.46 - 9.99 | ||
| Shares Outstanding (Mil) | 147.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gaush Meditech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gaush Meditech Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.300000 Cash Dividend | 2025-06-23 | 6.68 (-0.60%) |
Show
Entries
Gaush Meditech Ltd Frequently Asked Questions
What is Gaush Meditech Ltd(HKSE:02407)'s stock price today?
The current price of HKSE:02407 is HK$4.90. The 52 week high of HKSE:02407 is HK$9.99 and 52 week low is HK$4.46.
When is next earnings date of Gaush Meditech Ltd(HKSE:02407)?
The next earnings date of Gaush Meditech Ltd(HKSE:02407) is .
Does Gaush Meditech Ltd(HKSE:02407) pay dividends? If so, how much?
The Dividend Yield %  of Gaush Meditech Ltd(HKSE:02407) is 6.12% (As of Today), Highest Dividend Payout Ratio of Gaush Meditech Ltd(HKSE:02407) was 1.68. The lowest was 0.41. And the median was 1.05. The  Forward Dividend Yield % of Gaush Meditech Ltd(HKSE:02407) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gaush Meditech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers